YINOW ELECTRIC
837046
SUGON DATA ENERGY
872808
Dark Horse Technology Group
300688
Shenzhen L&A Design
300949
Shanghai Kaytune Industrial
301001
CN Stock MarketDetailed Quotes
003020 Hefei Lifeon Pharmaceutical
- 18.76
- +0.19+1.02%
Market Closed Dec 19 15:00 CST
3.59BMarket Cap20.62P/E (TTM)
18.84High18.34Low15.92KlotVolume18.51Open18.57Pre Close29.57MTurnover1.15%Turnover Ratio15.86P/E (Static)191.57MShares23.4652wk High2.08P/B2.59BFloat Cap13.3252wk Low20.43Limit Up138.04MShs Float36.80Historical High16.71Limit Down2.69%Amplitude12.36Historical Low0.42Dividend TTM18.57Avg Price7.87KlotAsk2.22%Div YieldTTM100Lot Size7.66KlotBid
Hefei Lifeon Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -19.46%1.17B | -25.79%758.89M | -37.66%375.55M | -31.49%1.7B | -18.63%1.46B | -7.81%1.02B | 39.30%602.44M | 22.11%2.48B | 30.22%1.79B | 19.81%1.11B |
| Refunds of taxes and levies | 188.38%2.62M | -82.36%160.35K | --122.13K | 139.97%871.06K | 56.43%908.98K | 99.86%908.98K | ---- | -91.77%362.98K | 397.94%581.08K | 289.72%454.8K |
| Cash received relating to other operating activities | -13.91%25.49M | -23.42%13.79M | -81.40%5.99M | 7.68%67.93M | -38.10%29.6M | -59.91%18.01M | -62.78%32.19M | 172.07%63.09M | 154.07%47.82M | 342.18%44.93M |
| Cash inflows from operating activities | -19.22%1.2B | -25.80%772.84M | -39.86%381.67M | -30.50%1.77B | -19.12%1.49B | -9.80%1.04B | 22.29%634.64M | 23.55%2.55B | 31.93%1.84B | 23.34%1.15B |
| Goods services cash paid | -60.44%279.97M | -67.58%181.85M | -66.24%105.76M | -49.16%755.07M | -33.63%707.67M | -8.17%560.97M | 27.48%313.22M | 36.73%1.49B | 66.06%1.07B | 20.40%610.85M |
| Staff behalf paid | 30.38%142.05M | 26.17%101.93M | 21.83%58.9M | 6.02%151.11M | 0.98%108.95M | 4.08%80.79M | 3.49%48.35M | 15.52%142.52M | 19.01%107.9M | 19.20%77.62M |
| All taxes paid | 40.58%140.73M | 6.21%92.15M | 15.74%48.58M | -0.98%150.81M | -5.95%100.11M | 4.32%86.76M | -13.00%41.97M | 26.24%152.29M | 18.04%106.45M | 41.69%83.16M |
| Cash paid relating to other operating activities | 0.72%511.19M | 25.97%319.19M | -26.99%152.94M | -10.05%510.25M | 17.34%507.54M | 0.83%253.39M | 27.53%209.49M | -1.05%567.26M | -4.63%432.55M | -4.73%251.31M |
| Cash outflows from operating activities | -24.60%1.07B | -29.21%695.12M | -40.27%366.18M | -33.23%1.57B | -16.86%1.42B | -4.01%981.91M | 21.41%613.04M | 23.31%2.35B | 34.21%1.71B | 14.30%1.02B |
| Net cash flows from operating activities | 104.37%126.68M | 30.28%77.72M | -28.32%15.48M | 1.51%203.67M | -50.19%61.98M | -54.72%59.65M | 54.12%21.6M | 26.42%200.64M | 6.94%124.44M | 219.46%131.73M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -23.61%275M | 250.00%175M | ---- | -19.85%759M | 4,400.00%360M | --50M | ---- | -40.45%946.92M | --8M | ---- |
| Cash received from returns on investments | -93.52%6.03M | -93.58%3.21M | --1.46M | 236.34%125.75M | 197.95%93.13M | 3,878.07%50.05M | ---- | 152.61%37.39M | 267.12%31.26M | -65.70%1.26M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 198.85%29.11K | 541.05%32.05K | ---- | -64.66%117.93K | -74.54%9.74K | -84.06%5K | 79.37%-1.36K | 25.19%333.69K | -67.63%38.25K | -81.85%31.35K |
| Cash received relating to other investing activities | ---- | ---- | ---- | --27.32M | ---- | ---- | ---- | ---- | -48.84%550M | -70.00%180M |
| Cash inflows from investing activities | -37.97%281.06M | 78.15%178.25M | 107,532.79%1.46M | -7.36%912.19M | -23.11%453.14M | -44.81%100.05M | 79.37%-1.36K | -38.65%984.64M | -45.62%589.29M | -69.98%181.29M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -24.37%108.14M | -15.76%95.21M | -20.31%48.66M | -19.84%197.54M | 6.27%142.98M | 30.40%113.03M | 18.04%61.06M | 31.82%246.43M | -12.02%134.55M | -1.64%86.68M |
| Cash paid to acquire investments | -29.65%383.41M | -33.33%270M | -17.29%281.22M | -15.43%795M | --545M | --405M | -22.73%340M | -41.61%940.02M | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | -88.93%24.48M | --24.48M | ---- | --209.35M | --221.1M | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --25.15M | -97.17%25.15M | -95.66%25.15M | ---- | ---- | -39.66%890M | -46.05%580M |
| Cash outflows from investing activities | -44.76%516.03M | -28.26%389.69M | -17.75%329.88M | 3.42%1.23B | -8.82%934.23M | -18.52%543.18M | -18.44%401.06M | -33.97%1.19B | -37.83%1.02B | -43.65%666.68M |
| Net cash flows from investing activities | 51.16%-234.97M | 52.28%-211.44M | 18.11%-328.42M | -56.02%-314.85M | -10.53%-481.1M | 8.71%-443.13M | 18.44%-401.06M | -5.17%-201.8M | 22.87%-435.26M | 16.21%-485.39M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 166.51%72.08M | -82.97%4.61M | ---- | ---- | --27.05M | --27.05M | ---- |
| Cash from borrowing | -31.89%28.6M | ---- | ---- | --41.99M | --41.99M | --41.99M | --41.99M | ---- | ---- | ---- |
| Cash received relating to other financing activities | -99.25%517.73K | -99.32%465.51K | -86.22%63.1K | 35.78%1.04M | --68.95M | --68.86M | --458.03K | --768.68K | ---- | ---- |
| Cash inflows from financing activities | -74.80%29.12M | -99.58%465.51K | -99.85%63.1K | 313.88%115.12M | 327.23%115.54M | --110.86M | --42.45M | --27.81M | -58.29%27.05M | ---- |
| Dividend interest payment | 56.29%96.37M | 55.71%96.01M | ---- | 3.75%67.28M | -4.92%61.66M | -4.92%61.66M | ---- | 40.00%64.85M | 39.46%64.85M | 38.27%64.85M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --6M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -20.94%7.38M | -10.91%5.76M | -21.34%2.5M | 2.69%11.21M | 2.66%9.34M | 11.37%6.46M | 2.63%3.18M | -10.36%10.91M | -88.35%9.1M | -87.29%5.8M |
| Cash outflows from financing activities | 46.14%103.75M | 49.39%101.76M | -21.34%2.5M | 3.60%78.49M | -3.98%71M | -3.58%68.12M | 2.63%3.18M | 29.52%75.76M | -40.63%73.94M | -23.66%70.65M |
| Net cash flows from financing activities | -267.54%-74.63M | -337.03%-101.3M | -106.20%-2.44M | 176.38%36.63M | 194.99%44.55M | 160.49%42.74M | 1,369.19%39.28M | 18.03%-47.95M | 21.46%-46.9M | -60.67%-70.65M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -119.52%-8.84K | -96.98%1.39K | 140.98%1.61K | -89.25%43.34K | -89.02%45.29K | -83.16%45.92K | 87.81%-3.94K | 322.78%403.05K | 1,030.80%412.35K | 487.81%272.67K |
| Net increase in cash and cash equivalents | 51.15%-182.94M | 31.02%-235.02M | 7.30%-315.37M | -52.95%-74.51M | -4.82%-374.52M | 19.65%-340.69M | 29.25%-340.19M | 46.97%-48.71M | 29.62%-357.3M | 27.15%-424.03M |
| Add:Begin period cash and cash equivalents | -12.91%502.72M | -12.91%502.72M | -12.91%502.72M | -7.78%577.23M | -7.78%577.23M | -7.78%577.23M | -4.70%577.23M | -12.80%625.94M | -12.80%625.94M | -12.80%625.94M |
| End period cash equivalent | 57.76%319.78M | 13.17%267.7M | -20.96%187.35M | -12.91%502.72M | -24.54%202.71M | 17.15%236.54M | 89.89%237.04M | -7.78%577.23M | 27.86%268.64M | 48.78%201.91M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.